Early Inflammatory Reactions in Atherosclerosis Are Induced by Proline-Rich Tyrosine Kinase/Reactive Oxygen Species–Mediated Release of Tumor Necrosis Factor-&agr; and Subsequent Activation of the p21Cip1/Ets-1/p300 System

Objective—Reactive oxygen species (ROS) are involved in the initial process of atherosclerosis, whereas it remains to be determined how atherogenic stimulus causes ROS-mediated proinflammatory reactions. Here, we focused on proline-rich tyrosine kinase (PYK2)–mediated ROS generation and examined how atherogenic stimulus causes early proinflammatory reactions. Methods and Results—PYK2-deficient (knockout [KO]) (PYK2-KO) mice were crossbred with apolipoprotein E (ApoE)–deficient (PYK2-KO/ApoE-KO) mice. PYK2-KO/ApoE-KO mice and endothelial cells (EC) were used for the study. Aortic atherogenic lesions in PYK2-KO/ApoE-KO mice were markedly decreased (55% versus ApoE-KO) after 8 weeks of a Western diet. Aortic PYK2 was activated as early as 7 days after the Western diet, when inflammatory cells were not yet activated. Addition of the proatherogenic oxidized phospholipid lysophosphatidylcholine caused activation of endothelial PYK2. Lysophosphatidylcholine-activated PYK2 induced NADPH oxidase–mediated ROS generation and ROS-mediated synthesis of tumor necrosis factor-&agr; (TNF&agr;), vascular cell adhesion molecule-1 (VCAM-1), monocyte chemotactic protein-1 (MCP-1), and p21Cip1/Ets-1. Neutralizing anti-TNF&agr; antibody or knockdown of p21Cip1/Ets-1 system blocked the induction of VCAM-1 and MCP-1. PYK2 deficiency abolished these ROS-mediated proinflammatory reactions. Further analysis revealed that PYK2/ROS-mediated p21Cip1/Ets-1 activation upregulated the transcription of the MCP-1 gene in collaboration with p300 transcription coactivator. Conclusion—PYK2 is a key tyrosine kinase activated by high cholesterol exposure, which causes ROS-mediated TNF&agr; release and induces TNF&agr;-dependent expression of proinflammatory molecules via the p21Cip1/Ets-1/p300 transcription system.

[1]  A. Lumsden,et al.  Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[2]  S. Lev,et al.  Activation of Pyk2 by Stress Signals and Coupling with JNK Signaling Pathway , 1996, Science.

[3]  M. Sheetz,et al.  Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[5]  K. Dellsperger,et al.  Role of TNF-α in vascular dysfunction , 2009, Clinical science.

[6]  J. Keaney,et al.  EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis. , 2005, American journal of physiology. Heart and circulatory physiology.

[7]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[8]  P. Oettgen,et al.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. , 2005, The Journal of clinical investigation.

[9]  H. Matsubara,et al.  Central Role of Calcium-Dependent Tyrosine Kinase PYK2 in Endothelial Nitric Oxide Synthase–Mediated Angiogenic Response and Vascular Function , 2007, Circulation.

[10]  P. Corr,et al.  Amphipathic metabolites and membrane dysfunction in ischemic myocardium. , 1984, Circulation research.

[11]  G. Condorelli,et al.  Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation‐sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  I. Komuro,et al.  Angiotensin II Induces Premature Senescence of Vascular Smooth Muscle Cells and Accelerates the Development of Atherosclerosis via a p21-Dependent Pathway , 2006, Circulation.

[13]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[14]  P. Dentelli,et al.  Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf). , 2002, The Journal of clinical investigation.

[15]  Anindya Dutta,et al.  p21 in cancer: intricate networks and multiple activities , 2009, Nature Reviews Cancer.

[16]  R. Ganju,et al.  LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway. , 2009, Molecular immunology.

[17]  G. Hatch,et al.  Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. , 1994, Cardiovascular research.

[18]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Abe,et al.  Fluid Shear Stress Activates Proline-Rich Tyrosine Kinase via Reactive Oxygen Species–Dependent Pathway , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[20]  R. Frey,et al.  NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. , 2009, Antioxidants & redox signaling.

[21]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[22]  E. Peles,et al.  Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.

[23]  N. Perkins,et al.  A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation , 2000, Molecular and Cellular Biology.

[24]  H. Matsubara,et al.  Erythropoietin-Mobilized Endothelial Progenitors Enhance Reendothelialization via Akt–Endothelial Nitric Oxide Synthase Activation and Prevent Neointimal Hyperplasia , 2006, Circulation research.